ARCHIVES

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

NCI’s Justification For 1981 Budget

June 8, 1979

Abstracts Of Papers From Therapeutic Radiology Meeting

November 21, 1975

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Authorization Bill Passes Senate 82-0

June 27, 1980

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989